These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3587296)

  • 21. Tetrahydroaminoacridine and Alzheimer's disease.
    Levy R
    Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126
    [No Abstract]   [Full Text] [Related]  

  • 22. Tetrahydroaminoacridine in Alzheimer's disease.
    Walsh AC
    BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129
    [No Abstract]   [Full Text] [Related]  

  • 23. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
    Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720
    [No Abstract]   [Full Text] [Related]  

  • 24. Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results.
    Boller F; Forette F
    Biomed Pharmacother; 1989; 43(7):487-91. PubMed ID: 2684292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence.
    Francis PT; Bowen DM
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):504-10. PubMed ID: 2572313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrine granted marketing approval for Alzheimer's disease.
    Clin Pharm; 1993 Dec; 12(12):873, 876. PubMed ID: 8137602
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrine for Alzheimer's.
    Handly M
    Am Pharm; 1991 Dec; NS31(12):8. PubMed ID: 1763782
    [No Abstract]   [Full Text] [Related]  

  • 29. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.
    Summers WK; Majovski LV; Marsh GM; Tachiki K; Kling A
    N Engl J Med; 1986 Nov; 315(20):1241-5. PubMed ID: 2430180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of tacrine hepatotoxicity in patients with Alzheimer disease or AIDS].
    Fredj G; Dietlin F; Barbier G; Jasmin C; Bonhomme L; Esctein S; Misset JL; Meyer P; Kalifa D; Beugre T
    Therapie; 1992; 47(3):245-7. PubMed ID: 1295125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tacrine in Alzheimer's disease: or non-effect?
    Talmont DM; Bowden M
    Med J Aust; 1995 Jan; 162(1):52-3. PubMed ID: 7710524
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA), a potential drug for treatment of Alzheimer's disease, on the physical state of human erythrocyte membranes.
    Palmieri DA; Butterfield DA
    Prog Clin Biol Res; 1989; 292():419-24. PubMed ID: 2726917
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.
    Summers WK; Viesselman JO; Marsh GM; Candelora K
    Biol Psychiatry; 1981 Feb; 16(2):145-53. PubMed ID: 7225483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrine as a treatment for Alzheimer's dementia: editor's note. An interim report from the FDA. A response from Summers et al.
    N Engl J Med; 1991 Jan; 324(5):349-52. PubMed ID: 1986300
    [No Abstract]   [Full Text] [Related]  

  • 36. Tetrahydroaminoacridine in HIV infections. The THA Study Group.
    Fredj G; Dietlin F; Fredj D; Schwarzenberg L; Jasmin C; Meyer P; Misset JL
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):408-10. PubMed ID: 2793276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia].
    Chatellier G
    Rev Prat; 1993 Mar; 43(6):725-8. PubMed ID: 8341950
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of tacrine for tardive dyskinesia.
    Ingram NA; Newgreen DB
    Am J Psychiatry; 1983 Dec; 140(12):1629-31. PubMed ID: 6650699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment issues in clinical trials of tetrahydroaminoacridine and studies to alter decline in Alzheimer disease.
    Thal LJ
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S37-9. PubMed ID: 1781972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrine: a second look. An outdated drug to be discarded.
    Prescrire Int; 1999 Feb; 8(39):16-8. PubMed ID: 10557569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.